Literature DB >> 11200563

Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.

E Y Chin1, C A Dangler, J G Fox, D B Schauer.   

Abstract

The T cell receptor alpha chain-deficient (TCR alpha-/-) and TCR beta chain-deficient (TCR beta-/-) mice develop chronic intestinal inflammation that resembles inflammatory bowel disease by 3 to 4 months of age. The objective of the study reported here was to determine the role of infection with the bacterial pathogen Helicobacter hepaticus in the pathogenesis of disease in TCR alphabeta mutant mice. The H. hepaticus-infected TCR alphabeta mutant mice were rederived by use of embryo transfer to produce Helicobacter-free animals. Helicobacter-free TCR alpha-/-, TCR beta-/-, and TCR alpha-/- beta-/- mice were inoculated with H. hepaticus. Experimentally infected mice and uninfected control mice were examined for intestinal lesions at 3, 6, and 9 months after inoculation. The TCR alphabeta mutant mice inoculated with H. hepaticus developed intestinal epithelial cell hyperplasia and mucosal inflammation. By 6 months after inoculation, infected animals had moderate cecal and colonic lesions. Helicobacter-free TCR alpha-/- mice, but not TCR beta-/- or TCR alpha-/- x beta-/- mice, also developed H. hepaticus-independent colitis by 9 months after inoculation. Infection with H. hepaticus is sufficient to cause chronic proliferative intestinal inflammation in TCR alphabeta mutant mice. However, H. hepaticus infection is not necessary for intestinal disease in TCR alpha-/- mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11200563

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  33 in total

Review 1.  The role of microorganisms in biliary tract disease.

Authors:  Asa Ljungh; Torkel Wadström
Journal:  Curr Gastroenterol Rep       Date:  2002-04

2.  Chronic Helicobacter infection of the human liver and bile are common and may trigger autoimmune disease.

Authors:  Torkel Wadström; And Asa Ljungh
Journal:  Curr Gastroenterol Rep       Date:  2002-10

3.  Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease.

Authors:  Ulrich R M Bohr; Bernhard Glasbrenner; Anett Primus; Alexandra Zagoura; Thomas Wex; Peter Malfertheiner
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.

Authors:  Katharine H Banner; Christophe Cattaneo; Jean-Loic Le Net; Aleksandar Popovic; David Collins; Jeremy D Gale
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

Review 5.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

6.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

Review 7.  Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease.

Authors:  J G Fox
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

8.  Isolation of Helicobacter spp. from mice with rectal prolapses.

Authors:  Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; James G Fox
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

9.  Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Authors:  Todd Atherly; Curtis Mosher; Chong Wang; Jesse Hostetter; Alexandra Proctor; Meghan W Brand; Gregory J Phillips; Michael Wannemuehler; Albert E Jergens
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

10.  Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease.

Authors:  Toshihide Hamada; Kenji Yokota; Kiyoshi Ayada; Kazuyuki Hirai; Tomoari Kamada; Ken Haruma; Kazuaki Chayama; Keiji Oguma
Journal:  Helicobacter       Date:  2009-12       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.